Garamycin and Thrombocytopenia - a phase IV clinical study of FDA data

Summary:

Thrombocytopenia is reported as a side effect among people who take Garamycin (gentamicin sulfate), especially for people who are male, 60+ old, also take Prednisone, and have Ards (acute respiratory distress syndrome).

The phase IV clinical study analyzes which people have Thrombocytopenia when taking Garamycin. It is created by eHealthMe based on reports of 436 people who have side effects when taking Garamycin from the FDA, and is updated regularly.

What is Garamycin?

Garamycin has active ingredients of gentamicin sulfate. eHealthMe is studying from 440 Garamycin users. Check the latest studies of Garamycin.

What is Thrombocytopenia?

Thrombocytopenia (decrease of platelets in blood) is found to be associated with 2,791 drugs and 4,870 conditions by eHealthMe. Check the latest studies of Thrombocytopenia.

On Jul, 16, 2026

436 people reported to have side effects when taking Garamycin.
Among them, 13 people (2.98%) have Thrombocytopenia.

Among these 13 people:

What is the gender of people who have Thrombocytopenia when taking Garamycin? *

female: 30.77 %
male: 69.23 %

What is the age of people who have Thrombocytopenia when taking Garamycin? *

What are other drugs people take besides Garamycin? *

What are other side effects people have besides Thrombocytopenia? *

Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 6 people, 46.15%
Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung): 5 people, 38.46%
Cardiac Failure: 5 people, 38.46%
Hypotension (abnormally low blood pressure): 5 people, 38.46%
Peritonitis (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs): 5 people, 38.46%
Hepatocellular Injury (liver injury): 5 people, 38.46%
Ards (Acute Respiratory Distress Syndrome) (sudden failure of the respiratory (breathing) system): 5 people, 38.46%
General Physical Health Deterioration (weak health status): 3 people, 23.08%
Heart Attack: 3 people, 23.08%
Disseminated Intravascular Coagulation (systemic activation of blood coagulation): 3 people, 23.08%

What are the existing conditions these people have? *

Nausea (feeling of having an urge to vomit): 2 people, 15.38%
Juvenile Arthritis (arthritis-related condition that develops in children or teenagers): 2 people, 15.38%
Heart Attack: 2 people, 15.38%
Embolism (obstruction of an artery, typically by a clot of blood or an air bubble): 2 people, 15.38%
Ards (Acute Respiratory Distress Syndrome) (sudden failure of the respiratory (breathing) system): 2 people, 15.38%
Psoriasis (immune-mediated disease that affects the skin): 1 person, 7.69%
Lung Cancer - Non-Small Cell (lung cancer): 1 person, 7.69%
Leukocytosis (increased white blood cells): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Garamycin and have Thrombocytopenia?

- Check whether Thrombocytopenia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Garamycin:

Garamycin (440 reports)

Thrombocytopenia treatments and more:

Thrombocytopenia (285,083 reports)

Browse all side effects of Garamycin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Thrombocytopenia:

Thrombocytopenia (2,791 drugs)

Browse all the conditions that are associated with Thrombocytopenia:

Thrombocytopenia (4,870 conditions)

Related publications that referenced our studies

YavasogluI, I., TurgutkayaII, A., & BolamanIII, Z., "Chlorella-induced thrombocytopenia", DATA, 2018 Jan .
Rasmy A, Rahal M, Kisana M, Ahmad S, Salah A, "Morphine induced thrombocytopenia: A case report", Journal of Case Reports and Images in Oncology, 2015 Dec .
Onder H, Arsava EM, Arat A, Topcuoglu MA, "Acute middle cerebral artery occlusion treated by thrombectomy in a patient with myelodysplastic syndrome and severe thrombocytopenia", Journal of vascular and interventional neurology, 2015 Jan .
YavasogluI, I., TurgutkayaII, A., & BolamanIII, Z., "Chlorella-induced thrombocytopenia", DATA, 2018 Jan .
Rasmy A, Rahal M, Kisana M, Ahmad S, Salah A, "Morphine induced thrombocytopenia: A case report", Journal of Case Reports and Images in Oncology, 2015 Dec .
Onder H, Arsava EM, Arat A, Topcuoglu MA, "Acute middle cerebral artery occlusion treated by thrombectomy in a patient with myelodysplastic syndrome and severe thrombocytopenia", Journal of vascular and interventional neurology, 2015 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on gentamicin sulfate (the active ingredients of Garamycin) and Garamycin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.